1. Home
  2. KDLY vs EVOK Comparison

KDLY vs EVOK Comparison

Compare KDLY & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KDLY
  • EVOK
  • Stock Information
  • Founded
  • KDLY 2019
  • EVOK 2007
  • Country
  • KDLY United States
  • EVOK United States
  • Employees
  • KDLY N/A
  • EVOK N/A
  • Industry
  • KDLY
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • KDLY
  • EVOK Health Care
  • Exchange
  • KDLY NYSE
  • EVOK Nasdaq
  • Market Cap
  • KDLY 19.6M
  • EVOK 7.1M
  • IPO Year
  • KDLY 2024
  • EVOK 2013
  • Fundamental
  • Price
  • KDLY $2.89
  • EVOK $5.37
  • Analyst Decision
  • KDLY
  • EVOK
  • Analyst Count
  • KDLY 0
  • EVOK 0
  • Target Price
  • KDLY N/A
  • EVOK N/A
  • AVG Volume (30 Days)
  • KDLY 12.8M
  • EVOK 9.0K
  • Earning Date
  • KDLY 02-25-2025
  • EVOK 03-13-2025
  • Dividend Yield
  • KDLY N/A
  • EVOK N/A
  • EPS Growth
  • KDLY N/A
  • EVOK N/A
  • EPS
  • KDLY N/A
  • EVOK N/A
  • Revenue
  • KDLY $2,875,400.00
  • EVOK $8,617,036.00
  • Revenue This Year
  • KDLY N/A
  • EVOK $97.35
  • Revenue Next Year
  • KDLY N/A
  • EVOK $99.52
  • P/E Ratio
  • KDLY N/A
  • EVOK N/A
  • Revenue Growth
  • KDLY N/A
  • EVOK 100.35
  • 52 Week Low
  • KDLY $0.65
  • EVOK $3.54
  • 52 Week High
  • KDLY $5.25
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • KDLY N/A
  • EVOK 65.36
  • Support Level
  • KDLY N/A
  • EVOK $4.68
  • Resistance Level
  • KDLY N/A
  • EVOK $5.40
  • Average True Range (ATR)
  • KDLY 0.00
  • EVOK 0.33
  • MACD
  • KDLY 0.00
  • EVOK 0.07
  • Stochastic Oscillator
  • KDLY 0.00
  • EVOK 97.46

About KDLY KINDLY MD INC

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: